As used in this chapter, "gender transition hormone therapy" means:

1. (1) testosterone;
2. (2) estrogen; or

3. (3) progesterone;

   given to an individual in an amount greater than would normally be produced endogenously in a healthy individual of that individual's age and sex.

As added by P.L.10-2023, SEC.1.